David Haine, OD
Optometrist · Ashland, VANPI 1285619965
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 56.9% of the total. Reporting peaked in 2020 at $2,841 and has fallen 95.8% since, to $121 in 2025. Among optometrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $102.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$4K
- Alcon$611
- Optos, Inc.$374
- Mallinckrodt Hospital Products Inc.$363
- Sun Pharmaceutical Industries Inc.$342
- Maculogix, Inc.$316
- plus $1K from 9 others
What the payments were for
- Speaking & faculty fees$2,50032%
- Travel & lodging$1,52419%
- Food & beverage$3,65946%
- Education$981%
- Gifts$190%
- Entertainment$811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 20 | $4,482 |
| Alcon | 5 | $611 |
| Optos, Inc. | 7 | $374 |
| Mallinckrodt Hospital Products Inc. | 9 | $363 |
| Sun Pharmaceutical Industries Inc. | 11 | $342 |
| Maculogix, Inc. | 6 | $316 |
| AbbVie(2 entities) | 3 | $291 |
| Bausch & Lomb Americas Inc. | 3 | $264 |
| Coopervision Inc. | 3 | $261 |
| Sight Sciences, Inc. | 1 | $147 |
| Lombart Brothers, Inc. | 5 | $136 |
| Glaukos Corporation | 1 | $106 |
| Carl Zeiss Meditec USA, Inc. | 1 | $106 |
| Oyster Point Pharma, Inc. | 1 | $64 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOTRUE$3,752
- ULTRA$3,752
- TOTAL30$266
- MIEBO$240
- XIIDRA$240
- BIOTRUE ONE DAY$232
- VUITY$219
- TEARCARE SYSTEM$147
- Clareon$119
- DAILIES$118
- AdaptDx$114
- Precision 1$107
- CLARUS 500$106
How this compares
$7,881 in reported general payments places this provider in the 95th percentile of 1,230 optometrist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 164 | $2,138 |
| Travoprost | 22 | $1,719 |
| Timolol Maleate | 85 | $1,232 |
| Brimonidine Tartrate | 18 | $119 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 17 | $97 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Ashland
- Walter WhitleyNorfolk$546K
- Jacqueline TheisRichmond$80K
- Joseph AllenRichmond$75K
- Keith SmithsonReston$74K
- Michael SwattsChesapeake$59K
- Kurt DevitoVirginia Beach$54K
- Walter SchlabachHarrisonburg$31K
- Mark AbrahamFalls Church$30K
- David TangVirginia Beach$29K
- Tiffany LioneAldie$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.